Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John W. V Umstead Insider Profile
4 Followers
John W. V Umstead, CFO at G1 Therapeutics, holds 187.72K shares in G1 Therapeutics (Ticker: GTHX). Most recently, John W. V Umstead Sold $527 shares of G1 Therapeutics on Jul 08, 2024 for an estimated value of 1.32K.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-110.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John W. V Umstead's holdings
Insider Roles
CFO
Roles that John W. V Umstead holds in companies
Most Profitable Insider Trade
The most profitable trade made by John W. V Umstead
John W. V Umstead's Trading History
List of latest transactions for each holding click on a transaction to see John W. V Umstead's performance on stock
You May Also Like
John W. V Umstead insider profile FAQ
What is the percentage of profitable transactions made by John W. V Umstead?
The percentage of profitable transactions made by John W. V Umstead is 0%.
What is the average return per transaction made by John W. V Umstead?
The average return per transaction made by John W. V Umstead is -110.30%.
What stocks does John W. V Umstead hold?
John W. V Umstead holds: GTHX stocks.
What was John W. V Umstead’s latest transaction?
John W. V Umstead latest transaction was an Informative Sell of $1.32K.
What was John W. V Umstead's most profitable transaction?
John W. V Umstead’s most profitable transaction was an Informative Sell of GTHX stock on May 15, 2024. The return on the trade was -51.50%.
What is John W. V Umstead's role in G1 Therapeutics?
John W. V Umstead's role in G1 Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.